RhumbLine Advisers’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
+84,965
| New | +$121K | ﹤0.01% | 3465 |
|
|
2024
Q3 | – | Sell |
-42,005
| Closed | -$46.2K | – | 4195 |
|
|
2024
Q2 | $46.2K | Sell |
42,005
-55,215
| -57% | -$60.7K | ﹤0.01% | 3707 |
|
|
2024
Q1 | $121K | Buy |
97,220
+1,470
| +2% | +$1.82K | ﹤0.01% | 3384 |
|
|
2023
Q4 | $101K | Sell |
95,750
-6,684
| -7% | -$7.02K | ﹤0.01% | 3446 |
|
|
2023
Q3 | $702K | Sell |
102,434
-1,893
| -2% | -$13K | ﹤0.01% | 2403 |
|
|
2023
Q2 | $1.08M | Buy |
104,327
+16,571
| +19% | +$172K | ﹤0.01% | 2246 |
|
|
2023
Q1 | $710K | Buy |
87,756
+1,894
| +2% | +$15.3K | ﹤0.01% | 2281 |
|
|
2022
Q4 | $1.35M | Buy |
85,862
+2,370
| +3% | +$37.3K | ﹤0.01% | 1990 |
|
|
2022
Q3 | $1.31M | Buy |
83,492
+11,493
| +16% | +$181K | ﹤0.01% | 1997 |
|
|
2022
Q2 | $1.01M | Buy |
71,999
+16,805
| +30% | +$235K | ﹤0.01% | 2144 |
|
|
2022
Q1 | $952K | Buy |
55,194
+8,469
| +18% | +$146K | ﹤0.01% | 2150 |
|
|
2021
Q4 | $679K | Buy |
46,725
+1,424
| +3% | +$20.7K | ﹤0.01% | 2380 |
|
|
2021
Q3 | $815K | Buy |
45,301
+3,435
| +8% | +$61.8K | ﹤0.01% | 2326 |
|
|
2021
Q2 | $735K | Buy |
+41,866
| New | +$735K | ﹤0.01% | 2383 |
|
|
2020
Q2 | – | Sell |
-51,626
| Closed | -$54K | – | 3059 |
|
|
2020
Q1 | $54K | Sell |
51,626
-4,368
| -8% | -$4.57K | ﹤0.01% | 2853 |
|
|
2019
Q4 | $106K | Buy |
55,994
+1,935
| +4% | +$3.66K | ﹤0.01% | 2869 |
|
|
2019
Q3 | $58K | Buy |
54,059
+4,164
| +8% | +$4.47K | ﹤0.01% | 2917 |
|
|
2019
Q2 | $109K | Buy |
49,895
+3,933
| +9% | +$8.59K | ﹤0.01% | 2915 |
|
|
2019
Q1 | $275K | Buy |
45,962
+6,472
| +16% | +$38.7K | ﹤0.01% | 2589 |
|
|
2018
Q4 | $292K | Buy |
39,490
+13,269
| +51% | +$98.1K | ﹤0.01% | 2561 |
|
|
2018
Q3 | $381K | Sell |
26,221
-905
| -3% | -$13.2K | ﹤0.01% | 2389 |
|
|
2018
Q2 | $542K | Buy |
27,126
+4,943
| +22% | +$98.8K | ﹤0.01% | 2272 |
|
|
2018
Q1 | $389K | Buy |
22,183
+90
| +0.4% | +$1.58K | ﹤0.01% | 2320 |
|
|
2017
Q4 | $545K | Sell |
22,093
-1,955
| -8% | -$48.2K | ﹤0.01% | 2197 |
|
|
2017
Q3 | $621K | Buy |
24,048
+1,095
| +5% | +$28.3K | ﹤0.01% | 2209 |
|
|
2017
Q2 | $622K | Buy |
22,953
+11,266
| +96% | +$305K | ﹤0.01% | 2190 |
|
|
2017
Q1 | $349K | Buy |
11,687
+1,555
| +15% | +$46.4K | ﹤0.01% | 2429 |
|
|
2016
Q4 | $275K | Buy |
10,132
+1,940
| +24% | +$52.7K | ﹤0.01% | 2524 |
|
|
2016
Q3 | $210K | Buy |
+8,192
| New | +$210K | ﹤0.01% | 2654 |
|